National Conference 2026 - From Research to Reality: Insights from Skyhawk Therapeutics and Roche
Once limited to symptomatic management, HD clinical trials are now exploring disease-modifying strategies offering cautious optimism alongside significant scientific and ethical challenges. Presented by Pannie Trifillis from Skyhawk Therapeutics and Rita Gandhy MD from Roche.
▶︎
Unlock the Strategic Power of Industrial AI
▶︎
How to Get Into Harvard Medical School | Real Applicant Data & Acceptance Stats
▶︎
National Conference 2026 - The Huntington's Disease Clinical Trial Landscape
▶︎
Clara Mattei: capitalism is not natural - it’s enforced
▶︎
Astrophysicist WARNS: "You're Not Prepared For This"
▶︎
Ep. 2 - The Truth About Multi-Generational Parkinson's | This is Parkinson's
▶︎
The Hardest Questions in Physics | World Science Festival
▶︎
Pneumonia: Part 1 | Clinical Medicine
▶︎
Pentagon has never passed an audit: Here's where the money goes | Unreported
▶︎
How our surroundings shape health: A conversation between environmental scientists
▶︎
Shell's Flawed LNG Forecast Threatens LNG Canada 2
▶︎
Former Head of Shin Bet: Ami Ayalon on Israel vs Palestine - Jung & Naiv: Episode 839
▶︎
Yann LeCun: World Models: Enabling the next AI revolution
▶︎
CNS Infections | Clinical Medicine
▶︎
Sleep Doctor: If You Wake Up Between 1–3 AM, Your Body Is Trying To Warn You | Dr Michael Breus
▶︎
ADHD & How Anyone Can Improve Their Focus | Huberman Lab Essentials
▶︎
The AI Arms Race: How Artificial Intelligence is Reshaping Intelligence, Warfare and Global Power
▶︎
AI has hacked the code of human civilization | Yuval Noah Harari
▶︎
'He's Weak': Tucker Carlson on How Trump Failed America | The Mishal Husain Show
▶︎